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Introduction
Clostridium difficile is a Gram positive 
anaerobic, sporogenic bacterium that 
forms part of the intestinal microbiota. 
As all pathogens of the Clostridium 
genus, C. difficile is also characterized by 
the fact that only toxigenic strains cause 
the disease. C. difficile can produce three 
toxins: toxin A (TcdA; 308 kDa), toxin 
B (TcdB; 207 kDa), which are the main 
virulence factors, and binary toxin (CDT), 
which is supposed to be an additional 
virulence factor, though its role in disease 
development is yet to be elucidated 
(Davies et al., 2011). Toxigenic strains 
can produce all three toxins (A+B+CDT+), 
only toxins A and B (A+B+CDT–), only 
toxin B and binary toxin (A–B+CDT+) or 
just one toxin (A–B+CDT–, A–B–CDT+) 
(Rupnik and Janežič, 2016). Recently, 
Monot et al. (2015) also described a strain 
producing only toxin A and being free of 
toxin B (A+B–), which could influence the 
choice of diagnostic tests.
Toxins TcdA and TcdB belong to the 
family of large clostridial toxins (LCTs). 
Both toxins are cytotoxic; in addition, 
TcdA is also enterotoxic (Just et al., 
2000). The main consequences of TcdA 
activity are inflammatory changes in 
the intestinal wall and the collapse of 
close contacts between cells, resulting in 
diarrhoea and haemorrhagic necrosis. 
TcdB is responsible for the formation 
of ulcers and yellow-white coatings 
(pseudomembranes) on the colon wall 
(Voth and Ballard, 2005). CDT binary 
toxin, classified as clostridium binary 
toxins, is adenosine diphosphate-
ribosyltransferase and is cytotoxic 
(Perelle et al., 1997). CDT was initially 
attributed to animal strains, though 
isolates producing CDT were recently 
detected in humans, and were related to a 
more severe disease and higher mortality 
(Gerding et al., 2014).
The genes for toxin A (tcdA) and B 
(tcdB) and three additional genes (tcdR, 
tcdE, tcdC) are located in the pathogenicity 
locus (PaLoc; 19.6 kbp) on the 
chromosome, and has the characteristics 
of a mobile genetic element. Non-
toxigenic strains have a 115 bp sequence 
at the site of the PaLoc region (Hammond 
and Johnson, 1995). Depending on the 
differences in this locus, the strains are 
divided into 34 toxinotypes (Rupnik and 
Janežič, 2016). The expression of the tcdA 
and tcdB genes and the formation of TcdA 
and TcdB occurs in the late logarithmic 
and stationary stages of cell growth 
in response to various environmental 
signals (temperature, presence of glucose, 
Jana avberšek
veTerInarSka STanICa 48 (6), 465-476, 2017.466
amino acids, antibiotics and butyric acid) 
leading to various physiological changes 
in the cell and development of the disease 
(Voth and Ballard, 2005).
CDT encodes two genes: cdtA for 
the enzyme toxin subunit and cdtB for 
the transport toxin subunit, which are 
located on the chromosome (Perelle et al., 
1997). C. difficile strains can thus be free of 
CDT genes, have a complete (4.3 kbp) or 
shortened CDT sequence - pseudogenes 
cdtA in cdtB (2.3 kbp), which do not lead 
to the expression of a functional CDT 
(Gerič Stare et al., 2007). Carter et al. 
(2007) discovered that the functional cdt 
locus (CdtLoc) contained a third gene 
called cdtR, which most likely encoded a 
response regulator important for optimal 
expression of binary toxin. 
C. difficile is the most common 
cause of hospital intestinal infections 
(CDI) in humans. Because of the use 
of antibiotics, cytostatic treatment or 
surgery, normal intestinal microbiota is 
affected, allowing spore germination and 
consequent multiplication of C. difficile 
(Johnson and Gerding, 1998). CDIs cause 
mild diarrhoea, haemorrhagic colitis or 
severe pseudomembranous colitis and 
intestinal perforation (Bartlett et al., 
1978). Community-acquired CDI has 
recently increased in people who have 
not been hospitalized, have not been 
treated with antibiotics, and have no 
other risk factors for the development of 
the disease (Pituch, 2009; Khanna et al., 
2012). In these infections, PCR-ribotype 
078/toxinotype V is frequently present, 
which is one of the most common types 
in different animal species (Hensgens et 
al., 2012). 
C. difficile has been detected in various 
domestic and wild animals (horses, 
cattle, dogs, cats, ostriches, pigs, poultry, 
elephants, small ruminants…). Its role 
is that of a commensal or pathogenic 
bacteria in the digestive tract. C. difficile 
causes enterocolitis and diarrhoea mainly 
in neonatal piglets, calves and foals, 
while in elderly animals, the disease is 
most often associated with antibiotic 
treatment (Frazier et al. 1993; Baverud 
et al., 2003; Bojesen et al., 2006; Songer 
and Anderson, 2006; Keel et al., 2007; 
Clooten et al., 2008; Pirš et al., 2008; 
Simango and Mwakurudza, 2008; Koene 
et al., 2012; Knight and Riley, 2013; 
Silva et al., 2014). Piglets with C. difficile 
related diarrhoea can be underweighted 
and have an extended weaning time. 
Furthermore, Squire and Riley (2013) 
reported a 14% monthly mortality rate 
in piglets. Young animals are often 
clinically healthy carriers of C. difficile; 
however, colonisation rates decrease 
with age (Weese et al., 2010; Costa et al., 
2011, Rodriguez et al., 2012). It has been 
demonstrated that there is no difference 
in the presence of C. difficile in piglets 
with and without diarrhoea, whereas the 
disease caused by C. difficile in poultry 
has not yet been described, and it appears 
that poultry is merely a bacterial reservoir 
(Zidarič et al., 2008; Alvarez-Perez et al., 
2009).
Identical genotypes detected in 
animals, humans and food suggest the 
possibility of interspecies transmission 
of C. difficile (Jhung et al., 2008; Janežič 
et al., 2012). Animals could potentially 
represent a bacterial reservoir for 
human infections, especially in cases 
of community-acquired infections. In 
addition, C. difficile has been detected in 
food: in raw meat (pork, beef, chicken 
and turkey meat), prepared meat 
products, fish, shrimp, raw vegetables 
and prepared salads (Rupnik and Songer, 
2010; Metcalf et al., 2011).
Laboratory methods for 
Clostridium difficile detection
Several methods are described for the 
detection of C. difficile in faecal samples. 
Most have been validated for diagnostics 
in humans and could theoretically 
be used in veterinary medicine. The 
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methods used in human medicine are 
described and critically evaluated for use 
in veterinary medicine below.
Toxigenic culture
Laboratory diagnostics is based on 
toxigenic culture involving the isolation 
of the bacterium from faeces and further 
in vitro demonstration of toxins with a 
cytotoxicity test or enzyme immunoassay 
(EIA) (Delmee et al., 2005). Toxigenic 
culture is the most sensitive among the 
described methods (sensitivity of 94-
100%), but is time consuming and requires 
experienced personnel (Delmee, 2001; 
Cohen et al., 2010). Selective medium, 
i.e. fructose agar with cycloserine and 
cefoxitin (CCFA), is most frequently used 
for isolation (George et al., 1979) even 
though there are also other commercially 
available media, e.g. C. difficile agar 
with norfloxacin and moxalactam 
or chromogenic media Chrom ID C. 
difficile (BioMerieux, France) (Aspinall 
and Hutchinson, 1992). The media 
may contain various supplements that 
improve spore germination or enrich the 
medium (horse or sheep blood, egg yolk, 
lysozyme, cysteine, sodium taurocholate, 
etc.) or a colour changing indicator when 
C. difficile appears (CDSA agar with 
neutral red indicator; Becton Dickinson, 
USA) (Marler et al., 1992; Wilcox et al., 
2000). The selective medium is incubated 
for 48 hours in an anaerobic atmosphere 
at 37 °C. The sensitivity of the method is 
increased using heat (80 °C) or alcohol 
shock before inoculating the sample (the 
same volume of faeces and ethanol is 
mixed and incubated for 30 minutes to 
one hour) (Borriello and Honour, 1981). 
Arroyo et al. (2005) compared various 
bacterial isolation procedures. The most 
efficient was enrichment selective broth 
(fructose broth with cycloserine and 
cefoxitine; CCFB) with the addition of 
0.1% sodium taurocholate, which allowed 
better spore germination (Wilson et al., 
1982), in combination with alcoholic 
shock followed by isolation C. difficile 
on selective plates. Hink et al. (2013) 
published the first study comparing 
several media and methods for C. difficile 
isolation from faeces and rectal swabs. In 
both cases the best combination was heat 
shock (heating for 10 minutes at 80 °C), 
followed by inoculation of the sample 
into mannitol broth with cycloserine, 
cefoxitin, taurocholate, cysteine and 
lysozyme, and then after seven days 
isolation of C. difficile on TSA II (tryptic 
soy agar) with 5% sheep blood. The 
use of enrichment broth improves the 
sensitivity of the method by about 20%, 
but the procedure is prolonged to about 
nine days (Tenover et al., 2011).
Recent studies compared chromogen-
ic agar Chrom ID C. difficile (BioMerieux, 
France) with other selective agars and 
reported that black colonies could be ob-
served after 24h incubation, though sensi-
tivity significantly increased after 48h in-
cubation. Furthermore, chromogenic agar 
yields a higher recovery of C. difficile than 
other selective agars, with a sensitivity of 
100% and recovery of 94% (Carson et al., 
2013; Han et al., 2014; Yang et al., 2014).
Identification of C. difficile colonies is 
based on typical morphology, yellow-
green fluorescence under UV light, 
characteristic horse manure odour, 
gas liquid chromatography of colonies 
(evidence of butyric and iso-caproic acid) 
or detection of proline aminopeptidase 
with discs (Levett, 1984; Fedorko and 
Williams, 1997). The use of biochemical 
tests and antigenic latex agglutination 
usually does not give reliable results 
(Tenover et al., 2011). In recent years, 
laboratories with suitable equipment 
prefer identification of C. difficile with 
MALDI-TOF, which is reliable, fast and 
cheap (excluding initial costs for the 
machine) (Kim et al., 2016).
Cell cytotoxicity test
The reference method (˝gold 
standard˝) is still a cytotoxicity test for 
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the detection of toxin B, where cytopathic 
effects (cell rounding) are observed, 
though some authors prefer toxigenic 
culture as a reference method due its 
higher sensitivity (Cohen et al., 2010; 
Crobach et al., 2016). The most commonly 
used are Vero, Hep2, CHO or HeLa cells, 
with Vero cells being most sensitive. 
In the cytotoxicity test, the toxin is 
confirmed by neutralization with specific 
antibodies (Chang et al., 1978). The test is 
effective but has its shortcomings: lack of 
standardization, long turnaround time of 
24 to 48 hours and need for experienced 
staff and maintenance of cell cultures; in 
addition, rapid decay or small amount 
of toxin in the sample hamper visible 
cytopathic effects, which leads to false 
negative results (Freeman and Wilcox, 
2003; Delmee et al., 2005). On the other 
hand, false positive results may occur in 
neutralization with antibodies that can 
neutralize Clostridium sordellii lethal toxin 
(O’Connor et al., 2001). The cytotoxicity 
test is highly specific (99–100%) and has 
a good positive predictive value (PPV) 
(93–100%), while the sensitivity is lower 
(50–85%) compared to the toxicity culture 
(Stamper et al., 2009; Peterson et al., 2011).
Serological methods
Several commercial EIA tests are 
available for the detection of TcdB and/
or TcdA toxins in faeces, though these 
are less sensitive than the cytotoxicity 
test (Barbut et al., 1993; Planche et al., 
2008, Chand and Sod, 2011). The data 
about reliability of EIA tests vary; some 
studies report sensitivity of less than 
50% and rarely over 90%. Additionally, 
low PPV is also a concern, especially in 
a low prevalence population. Meanwhile, 
specificity (88–100%) and negative 
predictive value (NPV) (83–99%) are 
satisfactory in most cases (Crobrach 
et al., 2016). In human medicine, EIA 
tests are widely used for screening, but 
the use of tests capable of detecting the 
presence of both toxins is necessary 
(Johnson et al., 2001). Despite their low 
cost and easy and rapid performance 
(results are obtained in 2–4 hours), recent 
studies have discouraged the use of 
EIAs as stand-alone tests (Eastwood et 
al., 2009; Cohen et al., 2010; Carroll and 
Loeffelholz, 2011; Boyanton et al., 2012). 
Commercially available tests are either 
EIA in microwell plates or membrane 
immune-chromatographic/lateral flow 
membrane EIA.
The EIA can also prove the presence 
of glutamate dehydrogenase enzyme 
(GDH), which is a specific C. difficile 
antigen, but does not distinguish 
toxigenic strains from non-toxigenic 
(Zheng et al., 2004). GDH EIA tests are 
characterized by high NPVs, therefore 
they are mostly used as the first screening 
test in multi-stage algorithms for the 
diagnosis of C. difficile infections (Reller 
et al., 2007). Their sensitivity for toxin 
detection is higher than in EIA tests, 
although this varies by manufacturer (78–
100%) (Crobrach et al., 2016), while PPV 
is low (Shetty et al., 2011). In addition, 
the presence of a particular PCR-ribotype 
may reduce the sensitivity of the test, 
which raises concerns over its usefulness 
(Tenover et al., 2010).
Nucleic acid amplification tests 
(NAATs)
Over the past two decades, molecular 
methods such as PCR have been 
developed. These have reduced the need 
for experimental antibiotic treatment and 
consequently long-term hospitalization. 
Initially, molecular methods were limited 
to detection of the 16S rRNA gene and 
could not be used for differentiation 
between toxigenic and non-toxigenic 
strains. Subsequently developed PCR 
protocols included the detection of genes 
encoding toxins A and B (Gumerlock et 
al., 1993; Kato et al., 1993: Kuhl et al., 1993). 
Real-time PCR (rtPCR) for the detection 
of toxin genes is a faster and more 
sensitive, yet more expensive alternative. 
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Belanger et al. (2003) first described the 
use of rtPCR for the detection of tcdA 
and tcdB genes using molecular beacons 
on the SmartCycler (Cepheid, USA), but 
the tcdB genes in variant toxinotypes (III, 
IV, VI) were not detected. Later, several 
rtPCR protocols were published for the 
rapid detection of C. difficile in faeces, 
amplifying different target genes, using 
different chemistry and adapted for 
different thermocylcers. Compared with 
toxigenic culture as a gold standard, the 
sensitivity of in-house rtPCR tests ranges 
from 83 to 100%, the specificity is between 
88 and 99%, PPV 66-94% and NPV 96-
100% (Crobach et al., 2009).
Several commercial tests are available 
for the detection of toxigenic C. difficile 
directly in faeces, which are intended 
and tested for human use. At least 11 
commercial NAATs are approved by 
the US Food and Drug Administration 
(i.e. BD GenOhm, ProDesse ProGastro 
Cd, Cepheid GeneXpert, Meridian 
Illumigene, etc.). However, specific 
equipment is needed to perform these 
tests and the cost per sample is much 
higher than for EIA, which are the major 
disadvantages for laboratories already 
equipped for molecular diagnostics 
(Martinez-Melendez et al., 2017). Most 
commercial NAATs are based on rtPCR, 
while some use isothermal helicase-
dependent amplification with detection 
on an array or microparticle-based 
microarrays (Eckert et al., 2014). Several 
studies have been published to compare 
these tests with other methods. If the 
toxigenic culture was taken as a gold 
standard, the tests had a sensitivity of 
62–100%, specificity of 87–100%, PPV 
68–100% and NPV 95–100% (Martinez-
Melendez et al., 2017).
One of the molecular approaches 
approved by the FDA is the loop-
mediated isothermal amplification 
method (LAMP). The method is fast 
(1h) and its sensitivity, specificity and 
NPV are comparable to commercial 
rtPCR tests, while PPV is lower (83–92%) 
(Boyanton et al., 2012). Its disadvantage 
is that it only detects the tcdA gene, so 
false negative results for variant C. difficile 
types is observed (Lalande et al., 2011). 
Several authors have warned of the 
excessive sensitivity of NAATs, since 
the positive result does not necessarily 
reflect the actual C. difficile disease, but 
only the presence of C. difficile (Polage 
et al., 2015). Peterson and Robicsek 
(2009) therefore recommend testing only 
those patients meeting the criteria for 
recurrent episodes of diarrhoea, and the 
clinical picture of the subject should be 
considered when evaluating the results 
of the diagnostic method (Dubberke 
et al., 2011). Moreover, NAATs do not 
prove the presence of toxins, only genes; 
therefore, it is not possible to know 
whether the gene is expressed and the 
toxin produced (i.e. clinical specificity) 
(Carroll and Loeffelholz, 2011).
Testing algorithms
Currently available diagnostic 
methods are either quick and less 
sensitive/specific or sensitive/specific 
and long-lasting (Tenover et al., 2011). 
Therefore, it is recommended to use that 
two-step algorithms for the diagnosis of C. 
difficile infection in humans (Carroll, 2011). 
The first screening test should be sensitive 
with a high NPV (GDH EIA, NAATs), 
and positive samples are then confirmed 
by confirmation test (toxin EIA, toxigenic 
culture) (Crobach et al., 2016). 
Suitability of methods for the 
detection of Clostridium difficile in 
animals
All methods described above are 
potentially useful in veterinary medicine, 
though all have been developed and 
adapted for human use, with the exception 
of toxigenic culture for C. difficile isolation 
from faeces. In faecal samples from 
animals, there are often few vegetative 
cells and a higher number of spores; 
Jana avberšek
veTerInarSka STanICa 48 (6), 465-476, 2017.470
therefore, pre-use of the enrichment 
selective medium is recommended, 
which prolongs the turnaround time. 
Thitaram et al. (2011) compared two 
isolation protocols on swine and cattle 
faeces samples: a single alcoholic shock 
after enrichment in a selective broth and 
a double alcoholic shock before and after 
enrichment. In both cases, CCFA and 
TSA media were used after enrichment. 
Double alcohol shock proved to work 
better for swine samples, while single 
alcohol shock was more suitable for 
bovine samples. The choice of medium 
had a minor impact, but it is nevertheless 
recommended to use C. difficile selective 
medium as it was easier to obtain a pure 
C. difficile culture. Avberšek et al. (2013) 
described an optimal cultivation method 
by implementing broth enrichment 
(CCFB with taurocholate) for seven 
days with a previous alcohol shock and 
subsequent isolation of C. difficile on 
selective agar (CCFA).
Initially, the use of EIA predominated 
in the veterinary medicine, but tests 
were only validated on human samples. 
Chouicha and Marks (2006) compared 
five different EIA with a cytotoxicity 
test on dog stool samples and found 
that the sensitivity and specificity were 
inadequate for toxin detection in dog 
samples. A mismatch between the 
results of culture or PCR and EIA was 
also found in a C. difficile infected horse 
(Magdesian et al., 2002; Magdesian et 
al., 2006; Arroyo et al., 2007; Ruby et 
al., 2009). Meanwhile, Medina-Torres 
et al. (2010) reported congruent results 
between EIA and cytotoxicity test in 93% 
of diarrhoeic horses. Compared to the 
culture, EIA tests were also unsuitable for 
toxin detection in calf faeces (Rodriguez-
Palacious et al., 2006; Pirš et al., 2008). Two 
studies compared EIA and cytotoxicity 
tests in swine faeces (Post et al., 2002; 
Anderson and Songer, 2008). The first 
test had a sensitivity of 91% compared 
to the cytotoxicity test, but the second 
EIA test had a sensitivity of only 39% 
compared to the first EIA test. Keessen et 
al. (2011) compared three EIA tests and 
a commercial rtPCR BD GeneOhm Cdiff 
(BD Diagnostics, USA) on pig samples 
and found out that none of the compared 
tests is suitable as an independent method 
for the detection of C. difficile in pigs. 
The concordance between the results 
of the tests and the reference method 
was only in 16.9% of the samples. The 
best sensitivity (93%) and NPV (87.5%) 
were generated by rtPCR, so the authors 
suggested a two-stage algorithm for the 
detection of C. difficile in pigs (rtPCR as 
a screening test and toxigenic culture 
as a confirmation test of rtPCR-positive 
samples). In general, EIA toxin tests have 
a lower sensitivity in animals than in 
humans, and the use of EIAs for human 
diagnosis is not recommended without 
prior validation on animal samples.
Another study (Knight et al., 2014) 
compared five assays evaluated for use 
in humans on piglet faeces: GDH EIA, 
toxin EIA, LAMP, GeneOhm Cdiff rtPCR 
assay and direct culture on chromogenic 
agar Chrom ID C. difficile. None of the 
commercial EIA and molecular tests were 
suitable for use in piglets. The concordance 
with enrichment culture was 77.7–84.1% 
and the sensitivity ranged from 5.6–
42.9%. Promising results were obtained 
with direct culture on Chrom ID agar, 
as 96.8% concordance with enrichment 
culture was observed and there was no 
need of prereduction, alcohol shock or 
additional 24h incubation.
Hopman et al. (2011) tested 
commercial rtPCR BD GeneOhm Cdiff 
for the detection of C. difficile in swine 
faeces and compared the results with 
the toxigenic enrichment culture: 28% of 
the samples were positive with toxigenic 
culture, while all were negative with 
rtPCR. So far, few rtPCR protocols 
have been described for veterinary use. 
Houser et al. (2010) published a TaqMan 
rtPCR assay (tcdA, tcdB, cdtA, cdtB) for the 
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detection of C. difficile in calf faeces and 
food. Faeces samples (n=71) were tested 
directly with rtPCR. According to the 
results, the authors suggested that rtPCR-
negative samples should be cultured in 
a selective broth and incubated for 5–7 
days. Subsequently, DNA isolated from 
the broths should be amplified with 
rtPCR to obtain more reliable results. 
After the enrichment step, a 7% increase 
of rtPCR-positive samples was seen. 
Avberšek et al. (2011, 2013) described two 
different protocols for direct detection of 
variant toxigenic C. difficile (tcdA, tcdB, 
cdtB) strains in animal faeces. The first 
rtPCR was based on TaqMan technology, 
while the second was validated on 
LightCycler (Roche, Germany) using 
two hybridisation probes. TaqMan 
rtPCR was also compared with two other 
rtPCR tests (in-house rtPCR by van den 
Berg et al., 2006 and PCRFast C. difficile 
A/B commercial test, ifp Institut für 
Produktqualitet, Germany) validated 
on human samples. TaqMan rtPCR was 
found to be the most suitable as it detected 
all tested variant toxinotypes and gave the 
best results compared to culture method. 
Both rtPCR tests described by Avberšek 
et al. (2011, 2013) were also compared 
to each other and to culture method. 
Complete concordance of both rtPCR 
tests was shown in 97.7% of samples, 
while correlation with the culture was 
seen in 75% of samples. As rtPCR assays 
for direct detection of C. difficile in animal 
faeces were not adequate as stand-alone 
tests due to 12% of culture positive/rtPCR 
negative samples, an improvement of the 
rtPCR was implemented. A one-day pre-
enrichment step prior to rtPCR evidently 
increased the number of rtPCR positive 
samples. This procedure is also suitable 
as an accurate and rapid screening test for 
samples with a low number of C. difficile, 
as no culture positive/rtPCR negative 
samples were observed. It can also be 
used for reliable detection of C. difficile 
in subclinical animals, which could shed 
the bacteria and might play an important 
role in the spread of the infection. 
rtPCR methods could also be im-
proved by optimizing DNA extraction 
procedures from faeces. As C. difficile is 
sporogenic, spores are present in faeces 
and DNA extraction from spores could 
be difficult. DNA extraction from swine 
faeces could be improved using physical 
pre-treatment with repeated bead-beat-
ing or with commercial kits for DNA 
extraction from complex samples, which 
already include bead-beating in the man-
ufacturer’s instructions (Grzeskowiak et 
al., 2016; Avberšek et al., 2017).
Epidemiological studies often benefit 
from quantification of C. difficile in 
different samples. Bandelj et al. (2013) 
modified a protocol by Penders et al. 
(2005) validated for human samples. 
Quantitative rtPCR targeting 16S rRNA 
gene was validated according to MIQE 
guidelines for cattle faeces. 
Despite promising studies on 
rtPCR methods in the veterinary field, 
cultivation of bacteria should not be 
neglected, as further genotyping and 
antimicrobial susceptibility testing 
cannot be performed without the isolate.
In conclusion, laboratory diagnostics 
of C. difficile is also important in veterinary 
medicine. Although timely detection 
of C. difficile in animals is not as critical 
as in human medicine, reliable, cost-
effective and rapid assays are needed 
for diagnostics of neonatal diarrhoea, 
especially in piglets. Furthermore, 
knowledge about prevalence and 
genotypes of C. difficile in animals, food 
and the environment is essential to define 
the zoonotic potential of C. difficile.
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Abstract
Clostridium difficile (C. difficile) is an 
important pathogen responsible for nosocomial 
intestinal infections in humans. The number 
of community-acquired infections in patients 
without risk factors for infection has been 
increasing. In these cases, animals could act as 
a reservoir of C. difficile, which may be present 
in the animal digestive tract as a causative 
agent of enterocolitis and diarrhoea or as 
commensal bacteria. The overlap of human 
and animal C. difficile genotypes indicates 
the zoonotic potential of the bacterium, and 
specific genotypes capable of causing severe 
infections in animals and humans have been 
reported. Different methods are used in 
human medicine for laboratory detection of 
C. difficile, and a variety of commercial tests 
are available. Diagnostic methods are based 
on cultivation of C. difficile on selective media, 
detection of C. difficile toxins and molecular 
tests. All these methods could be potentially 
used in veterinary medicine; however, with 
the exception of culture methods, the use of 
commercial tests is limited for testing animal 
samples, as the test results often poorly 
correlate with culture results or are not capable 
of detecting the variant C. difficile toxinotypes 
that are common in animals. Currently, no 
testing algorithm is available for the detection 
of C. difficile in animals; the gold standard is 
toxigenic culture. Pre-enrichment in selective 
broth is the method of choice, though recently 
comparable results were obtained with direct 
culture on chromogenic agar Chrom ID C. 
difficile. Enzyme immunoassay (EIA) toxin 
tests have a lower sensitivity for animal 
samples, therefore the use of EIAs for human 
diagnosis is not recommended without prior 
validation on animal samples. As in human 
medicine, in-house molecular methods are 
useful for rapid detection of C. difficile. Real-
time PCR (rtPCR) assays are not adequate as 
a stand-alone test; however, implementation 
of a one-day pre-enrichment step prior to 
rtPCR evidently increased method sensitivity. 
The sensitivity of rtPCR assays could also 
be improved with modified DNA extraction 
procedures, including repeated bead-beating. 
Key words: Clostridium difficile, laboratory 
diagnostics, animals
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Bakterija Clostridium difficile (C. difficile) je 
važan patogen odgovoran za nozokomijalne 
crijevne infekcije ljudi. U zadnje vrijeme 
povećava se broj domicilnih infekcija u 
bolesnika bez rizičnih faktora za infekciju. U 
tim slučajevima životinje mogu biti rezervoar 
C. difficile, koja može biti prisutna u probavnom 
traktu životinje kao uzročnik enterokolitisa 
i proljeva ili kao komenzalna bakterija. 
Preklapanje ljudskih i životinjskih genotipova 
C. difficile ukazuje na zoonotski potencijal 
bakterije, a prijavljeni su i specifični genotipovi 
sposobni prouzročiti teže infekcije životinja 
i ljudi. U humanoj medicini primjenjuju se 
različite metode za laboratorijsko utvrđivanje 
C. difficile, a dostupan je i niz komercijalnih 
testova. Dijagnostičke metode temelje se na 
kultivaciji C. difficile na selektivnim medijima, 
utvrđivanju C. difficile toksina i molekularnim 
testovima. Sve se te metode mogu potencijalno 
primjenjivati u veterini; ali, izuzevši metode 
kulture, primjena komercijalnih testova 
ograničena je na testiranje životinjskih 
uzoraka, budući da su rezultati testova 
često u slaboj korelaciji s rezultatima 
kulture ili nemaju sposobnost uvtvrđivanja 
toksinotipova varijanti C. difficile, uobičajenih 
u životinja. U ovom trenutku nema dostupnog 
algoritma testiranja za utvrđivanje C. difficile u 
životinja. Zlatni standard je toksigena kultura. 
Prethodno obogaćivanje u selektivnom 
bujonu je metoda izbora, ali nedavno su 
dobiveni usporedivi rezultati direktnom 
kulturom na kromogenom agaru Chrom ID 
C. difficile. Enzimske imunopretrage (EIA) 
toksina imaju nižu razinu osjetljivosti za 
životinjske uzorke pa se stoga uporaba EIA 
testova ne preporučuje za dijagnostiku u ljudi, 
osim uz prethodnu validaciju na životinjskim 
uzorcima. Kao i u humanoj medicini, za brzo 
utvrđivanje C. difficile korisne su interne 
molekularne metode. Lančana reakcija 
polimerazom u stvarnom vremenu (rtPCR) 
nije primjerena kao samostalna pretraga, ali 
implementacijom jednodnevnog prethodnog 
obogaćivanja prije rtPCR pretrage naočigled 
je povećana osjetljivost metode. Osjetljivost 
rtPCR pretrage mogla se poboljšati i 
modificiranim postupcima ekstrakcije DNK, 
među kojima je i bead-beating. 
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